Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Fimasartan/Amlodipine Combination vs Coadministration
NCT02205151Phase 1Completed
- Sponsor
- Boryung
- Start
- Jul 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fimasartan and amlodipine in hypertension (HTN) (2 arms), sponsored by Boryung. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to the Last Measurable Concentration. Started Jul 2014; status: completed.
02
Drugs
fimasartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02205151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205151.